AICR: CRU: Exploring Omega 3s for Prostate Cancer Treatment

[Guest guest]

This article was sent to me by a breast cancer friend who was confused why

there was the disclaimer in the article. Prostate cancer is suffering from

our lack of research. I told her that I thought we would see more and more

of these as we move to a more evidence based system in our healthcare

system. What do you think?

Article snippet:

Prostate cancer is one of the most common cancers in America, affecting an

estimated one in six men. Now, with an AICR grant, molecular biologist

A. deGraffenried is turning up some promising findings on how fish oils may

play a role in treating an advanced form of this cancer.

Androgen deprivation therapy is a common treatment because androgen

stimulates prostate cancer growth. Androgen is a class of hormones.

Testosterone, which promotes male characteristics, is one of the most

familiar androgens. Starving cells of androgen is successful at first, but

typically within two to three years, some of the cancer cells begin to

thrive again.

The result: renewed prostate cancer growth that is often fatal.

The Omega-3 Link

To read the article:

http://www.aicr.org/site/News2?page=NewsArticle & id=13475 & news_iv_ctrl=0 & abbr

=res_

or

http://tinyurl.com/6kfgp6